Inventor
Allan R. Shepard
Inventor
Fort Worth, TX, US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C12NMicroorganisms or enzymes31%
C12YEnzymes8%
PatentTitleYear
7,838,507'RNAi inhibition of CTGF for treatment of ocular disorders'20107,622,454'RNAi inhibition of CTGF for treatment of ocular disorders'20097,592,324'RNAi-mediated inhibition of ocular targets'20097,351,407'Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2010Patents assigned to ALCON INC (4)· patent assignee history
2008–2010Based in Fort Worth, TX, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALCON INC | 4 | 2008–2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| Fort Worth, Texas, US | 4 | 2008–2010 |